Study of Hot Flashes and Night Sweats in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
This pilot study was designed to explore the effects of combined treatment with raloxifene
HCl 60 mg and oral 17 beta-estradiol 1mg/day on the number of vasomotor episodes (hot flashes
plus night sweats) in postmenopausal women discontinuing continuous combined hormone
replacement therapy (ccHRT) compared to women treated with raloxifene HCl 60 mg alone.